Home > Back to Publisher > Report Information

Commercializing Molecular Diagnostics: Products,Services,Companies and Global Market

Takeda Pacific
July 1, 2008
175 Pages - SKU: TAK1820211

Abstract Table of Contents Related Reports

Countries covered: Global

This report is about the molecular diagnostics market, including systems, consumables and clinical lab services. These key medical products and services use technologies that can detect single or multiple genomic, protein, metabolomic or other ‘-omic’ biomarkers.

The detailed study shows that molecular diagnostic companies are expecting continued strong growth. Takeda Pacific’s report shows the major areas of this dynamic market landscape. This report shows various views of this growing multi-billion dollar market. The study sizes the market and projects the 5-year trend. The report charts the developments of more than 80 companies involved in this dynamic industry.

This report discusses government regulatory initiatives to accelerate the approvals of emerging molecular diagnostics by integrating biomarkers and companion pharmacogenomic tests. Myriad, Veridex, Genomic Health, Agendia and others are gaining traction detecting cancers. Roche’s Affymetrix-based tests measure how patients respond to 30 or more currently marketed drugs. These products enable the emerging field of personalized medicine. The passing of the GINA law in the US might foster the growth of more molecular diagnostics, clinical lab services and other related genetic testing services.

This study is full of interesting data and includes more than 43 figures and tables. The tables provide data about technologies, companies, product pipelines, partnerships and more. The study also has additional data such as the global incidence and prevalence of major diseases. The report analyzes partnering deals and includes several years of alliance and M&A data.

Thirty-eight selected companies are profiled, with details including contact information, business and product overviews, alliances and patent or other financial details.

This report would benefit people with job titles including CEO, VPs, Director of Business Development, Research Directors, Entrepreneurs, Venture Capitalists, Investment Planners, Research Scientists, Consultants or Industry Analysts.

Consultants at Takeda Pacific developed this report. The company provides business consulting that focuses on facilitating business development and market research projects. The business projects may involve European, Japanese and North American Life Science companies. Since it’s founding in late 1992, TP has reviewed or analyzed thousands of Life Science and Technology firms for its clients.

During the past twelve years, Takeda Pacific has produced over 70 industry reports about emerging pharma, biotech, med-devices and technology companies and markets. Takeda Pacific also offers follow-up consulting or custom research consulting to assist in your business development, benchmarking, or market assessment projects.

1.Molecular Diagnostics Market Landscape: Biomarkers, `Omics' and Molecular Tests; The Global In Vitro Diagnostic Product and Clinical; Lab Service Business; Advancing Molecular Diagnostics; Commercializing Molecular Diagnostic Tests
2.Alliances and M&As in Molecular Diagnostics: Highlights of Alliances & M&As; Technical Development Applications
3.Manufacturer Strategies: MDx Manufacturers by Disease Areas; Notable Findings
4.Detection Technologies Used in Developing Molecular: Diagnostics
5.Market Size and Forecast: Molecular Diagnostic (MDx) Product & Clinical Lab; Service Market Sizes; Market Trends for Global Molecular Diagnostic (MDx); Products; MDx Total Global Market Size; Leading Molecular Diagnostic Manufacturers' Shares; Global Molecular Diagnostic Product Market by Disease; Segments; Global Molecular Diagnostic Product Market by Test; Sample Segments; Global Molecular Diagnostic Product Market by; Technologies; Global Molecular Diagnostic Product Market by Region; Global Molecular Diagnostic Clinical Lab Services; Market by Disease and Regions
6.Trends, Opportunities and Challenges: Key Trends for Molecular Diagnostics; Top Opportunities for the Future; Main Challenges
7.Selected Molecular Diagnostic Companies: Abbott Molecular; Affymetrix, Inc.; Agendia B.V.; Asuragen, Inc.; Becton Dickinson Diagnostics; Beckman Coulter, Inc.; bioMerieux SA; BioSite, Inc. (Inverness Medical Innovations); BML, Inc.; Celera Corporation; Cepheid; Chiron Corporation (Novartis); Combimatrix Molecular Diagnostics, Inc.; Dako A/S; diaDexus, Inc.; Diagnosticos Da America S.A. (DASA); Digene Corporation (Qiagen); Epigenomics AG; Exact Sciences Corporation; Genomic Health, Inc.; Gen-Probe, Inc.; Illumina, Inc.; Innogenetics NV; LabCorp; Luminex Corporation; Myriad Genetics, Inc.; Nanogen, Inc.; Nanosphere, Inc.; Nymox Pharmaceutical Corporation; Orion Genomics LLC; Quest Diagnostics, Inc.; Roche Molecular Diagnostics; Sequenom, Inc.; Siemens Healthcare Diagnostics (MDx business); Sonic Healthcare Limited; Third Wave Technologies, Inc.; Unilabs Group; Veridex, LLC (J&J Co.)
8.Appendix: Major Disease Population Sizes; Companies Mentioned in This Report; Molecular Diagnostics in Medical R&D; About Takeda Pacific; About the Authors
List of Tables: Table 1. Molecular IVD Test Applications; Table 2. Top 10 Molecular Diagnostics IVD Players; Table 3. Leading Global Independent MDx IVD Clinical Lab Services; Table 4. A Path to Developing a Molecular Diagnostic IVD; Table 5. Strategic Alliances Summary by Alliance Type, 2004 to 2007; Table 6. Summary of M&As by Year, Buyer, Alliance Type, Size, 2004 to 2007; Table 7. Alliances Summary by Major Diseases, Jan-2004 to Mar-2007; Table 8. Alliances for Molecular Diagnostics by Major Disease, 2007; Table 9. Alliances for Molecular Diagnostics by Major Disease, 2006; Table 10. Alliances for Molecular Diagnostics by Major Disease, 2005; Table 11. Alliances for Molecular Diagnostics by Major Disease, 2004; Table 12. Manufacturers by Disease Area, Company and Products; Table 13. Company Activities by Sample Material Totals and Shares; Table 14. Company Activities by Major Disease Totals and Shares; Table 15. Company Activities by `Product Status' Segment Totals and Shares; Table 16. Current and Next Generation MDx Technology Development; Table 17. Technologies Market Share: Current vs. Next-Gen. vs. Future by Product Pipelines; Table 18. Technologies, Companies and Relationship; Table 19. Technologies and MDx Products: Current and Next Generation Development; Table 20. Vendor Competition by Nucleic Acid Amplification Technologies for Clinical Molecular Diagnostics and by Estimated Shares and Revenues; Table 21. Examples of Selected MDx Equipment and Consumable Products; Table 22. Examples of MDx Clinical Lab Services and Prices; Table 23. Total Global MDx Market Size to 2012; Table 24. Global MDx Market Size and Forecast by Major Segments to 2012; Table 25. Molecular Diagnostic Manufacturer Revenues & Shares; Table 26. MDx Products by Major Diseases/ Applications & Revenues; Table 27. MDx Products by Test Material Segments & Revenues; Table 28. MDx Products by Technology Segments & Revenues; Table 29. MDx Product Market Size by Global Regions; Table 30. Molecular Diagnostic Lab Services by Disease Segments; Table 31. MDx Clinical Lab Services by Global Regions and Revenues; Table 32. Future Direction of Infectious Disease Tests; Table 33. Future Direction of Cancer Companion Tests and Targeted Medicine; Table 34. Future Direction of Cancer Tests; Table 35. CNS Tests Likely in Five Years; Table 36. Future Trends of Pharmacogenomics (PGx) Tests; Table 37. Genetic Tests for Risk Prediction; Table 38. Selected Companion Diagnostics (PGx) and Targeted Therapies; Table 39. Estimated Incidence and Prevalence of Patient Populations by Disease in the Developed World; Table 40. Top Health Risk Factors Leading to Death in the Developed World; Table 41. Companies Mentioned in This Report; Table 42. Summary of Molecular Diagnostics Technical Focus in Medical R&D
List of Illustrations: Figure 1. Global Molecular Diagnostics Business; Figure 2. The Fastest Growing IVD and Lab Services Businesses; Figure 3. Total Global MDx Market Size to 2012; Figure 4. Global MDx Market Size by Major Segments to 2012; Figure 5. MDx Products by Major Diseases/ Applications &; Revenues; Figure 6. MDx Products by Test Material Segments & Revenues; Figure 7. MDx Products by Technology Segments & Revenues; Figure 8. MDx Product Market Size by Global Regions; Figure 9. MDx Clinical Lab Services by Disease Segments; Figure 10. MDx Clinical Lab Services by Global Regions and Revenues

More Global Molecular Diagnostics Reports

In-Vitro Diagnostics (IVD) Market (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers & Microbiology Culture) – Global Trends & Forecasts to 2016 by MarketsandMarkets
The global in-vitro diagnostics (IVD) market was valued at $44 billion in 2011 and is expected to have a modest growth during the study period. ...

2012 World Molecular Diagnostics Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country by Venture Planning Group
This report provides a worldwide overview of the molecular diagnostics market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well as ...

2012 Global Molecular Diagnostics Market Outlook: Growth Opportunities and Strategies by Venture Planning Group
The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next ten years will witness significant ...

The 2012 Global Molecular Diagnostics Market: Facilities, Test Volumes, and Sales Forecasts by Country by Venture Planning Group
This report provides a worldwide overview of the molecular diagnostics market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well as ...

Genetic Testing by Global Industry Analysts
This report analyzes the worldwide markets for Genetic Testing in US$ Million. The US market is analyzed by the following Segments: Prenatal and Newborn Genetic ...

See all reports like this >>

Commercializing Molecular Diagnostics: Products,Services,Companies and Global Market

Share this report

Other tasks

Research Assistance

Related Markets

Molecular Diagnostics Reports

Free Alert Me service